Recovering Quality of Life Measure (ReQoL-20) chosen by international panel of experts for the new set of standards to measure and improve psychotic disorders globally
27th May 2020
The International Consortium for Health Outcome Measurement (ICHOM) have announced the release of their new standard set of measures for Psychotic Disorders. As part of this new standard set the Recovering Quality of Life outcome questionnaire (ReQoL-20) has been chosen as the measure for tracking 3 aspects of psychotic disorders – Quality of Life, Personal recovery, and Positive and negative symptoms.
The ICHOM Standard Set for Psychotic Disorders is the result of hard work by an international group (from Europe, the Americas, Asia and Australia) of leading psychiatrists, psychologists, mental health experts, measurement experts, and service user experts. The new standard set represents the outcomes that matter most to adults and adolescents (age 12 upwards) with psychosis. This marks an important step towards promoting data quality and availability whilst strengthening mental health care for this group.
The development of the ReQoL was led by researchers at School of Health and Related Research (ScHARR), the University of Sheffield and is exclusively available for licence from the Clinical Outcomes team at Oxford University Innovation. The ReQoL has grown rapidly in its recognition as a quality of life measure for assessment with people experiencing mental health difficulties. International recognition of the ReQoL is demonstrated by the rapid growth of the library of translations, with currently 18 available from Clinical Outcomes.
About ScHARR
The School of Health and Related Research (ScHARR) is part of the Faculty of Medicine, Dentistry and Health and comprises four academic sections; Design, Trials and Statistics; Health Economics and Decision Science; Health Services Research; Public Health. We are the largest department in the University with over 200 academic and research related staff undertaking research and teaching in the provision of health services and public health interventions. Over 100 Professional Services staff provide support to the School. The School has a strong focus on research with over 70% of staff primarily funded through research grants. At the same time, we have a large and successful portfolio of taught postgraduate (PGT) programmes and contribute significantly to the medical undergraduate programme. We have also been one of the main contributors to the University’s Knowledge Exchange (KE) income stream, from industry and the public sector.
For more information, visit https://www.sheffield.ac.uk/scharr
Email : scharr.reception@sheffield.ac.uk
About Clinical Outcomes
Clinical Outcomes (at Oxford University Innovation) is a UK-based company, solely owned by the University of Oxford, specializing in the management and support of high-quality Clinical Outcome Assessments. The Clinical Outcomes team has been active in supporting COA users for over 14 years and represents the wishes of COA developers from within academia, healthcare providers and commercial organizations. Our international clients, which includes over 750 new users every year, covers the healthcare spectrum including academic research, publicly and independently funded healthcare providers, medical device companies and the pharmaceutical sector.
For more information, visit https://innovation.ox.ac.uk/clinical-outcomes/
Email healthoutcomes@innovation.ox.ac.uk.
Press release sign up
